USRE24090E - Impregnated salt tablet - Google Patents
Impregnated salt tablet Download PDFInfo
- Publication number
- USRE24090E USRE24090E US24090DE USRE24090E US RE24090 E USRE24090 E US RE24090E US 24090D E US24090D E US 24090DE US RE24090 E USRE24090 E US RE24090E
- Authority
- US
- United States
- Prior art keywords
- tablet
- salt
- sodium chloride
- tablets
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 title description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 30
- 239000011780 sodium chloride Substances 0.000 description 15
- 238000004090 dissolution Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 238000007598 dipping method Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 238000005470 impregnation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010028813 Nausea Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 206010019332 Heat exhaustion Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000000979 retarding effect Effects 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- -1 refined parafiin Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Definitions
- My invention is concerned with a new and improved medicinal non-friable tablet of dense sodium chloride impregnated with. a skeletonal membranous structure to delay its rate of absorption by the human gastrointestinal tract.
- my invention relates to salt in tablet form, the granular particles of which are coated with membranous films of an edible, normally solid waxy material to bring about a desired retarding of the tablets dissolution time and the method for preparing the same.
- the dipping bath to which the tablets are introduced consists of refined, molten p'arafin of food grade purity having smelting point ranging from 122' to 124 F., although other paraffins having different melting ranges are available which are equally satisfactory for this purpose.
- the dipping time in this bath may vary'from 10 to 60 seconds with an average time of'20 seconds being preferred; an increase in dipping time over 2 seconds ap .pearing to have little effect on the parafiin' penetration and dissolution time of my tablet.
- the eflects of the parafiin penetration are variable according to whether the tablet is punched hard or soft. Formation pressures in the-neighborhood of 5 tons/sq. in.
- the treatment of the salt tablet in this manner has a I marked effect on its dissolution or disintegration time in water, tending to lengthen this test time over that of an untreated salt tablet.
- This effect is largely due to a skeletonal impregnating penetration of the tablet by the molten ,parafin whereby an internal honeycomb structure is formed; the separated cells of which encase small individual pockets of salt.
- Tablets punched "hard and dipped in molten paraflin for 20 seconds under my above described treatment have an average total distintegrating time of approximately 13 minutes while similar "soft” punched tablets dipped for 20 seconds have an average total disintegration time of approximately 73 minutes.
- a non-friable, internally reinforced tablet comprising substantially 10 grains of refined granular sodium chloride tableted'under formation pressures of from 5-10 tons per square inch, and an internally disposed cellular structure comprising substantially 8-28 milligrams of refined parafli'n, impregnated between and around the grains of the tableted sodium chloride while in a molten state
- said internal cellular structure permitting the osmotic dissolution of said sodium chloride therethrough in the presence of human gastrointestinal juices at a rate substantially less than the normal 'rate of dissolution of sodium chloride in such juices
- said internal cellular paraflin structure permitting the disillusnoted between and around the grains of the sodium chloride tablet while in a molten state and subsequently solidi- 5 fertil
- a non-friable, internally reinforced tablet comprising grains of refined granue.
- larsodium chloride tableted under formation pressure into squa're'irich and substantially 8-28 milligrams of waxy 0 substance are related for a tablet comprising substantially 10 grains of sodium chloride, said intern'al cellular paraffin structure permitting dissolution of said sodium chloride in the stomach at a rate substantially less than the normal rate ofdissolution of sodium chloride in the stomach.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Description
N. Original 1954, Se No. 198,037, November 28 24,090 a r IMPREGNATED SALT mam Honce Diamond, Chicago, 111., amlgnor to Morton SaltCompany,Chlcago,lll.,acorpontlonofllllnoh- No. 2,665,236, dated ham i950. Application for reissue November 3, 1954, Serial No. 466,706
3 Claims. (Cl. 167-82 I Matter enclosed inheavy bracket: [lappears In the orlghal patent but fornu no part of'this reissue specification; matter printed In italics Indicates the additions madebyreissue.
My invention is concerned with a new and improved medicinal non-friable tablet of dense sodium chloride impregnated with. a skeletonal membranous structure to delay its rate of absorption by the human gastrointestinal tract. In particular my invention relates to salt in tablet form, the granular particles of which are coated with membranous films of an edible, normally solid waxy material to bring about a desired retarding of the tablets dissolution time and the method for preparing the same.
It is now a familiar practice for humans to consume salt, especially in tablet form, to avert the ill effects of excessive heat and perspiring. This practice is most general among industrial workers, especially those in the steel or hke industries, and was endorsed with approval as a general beneficial practice for members of our Armed Forces during World War II. Experience has proven, however, that salt tablets formed without a deterring agent of some type dissolve so rapidly within the human stomach as to lead to violent nausea, apigastric discomfort and vomiting, causing greater than the heat effects which they are designed to combat. Various suggestions have been made for combating these'ill effects, but the most promising solution to date appears to lie in attempting to retard the rate of absorption or dissolution of the salt tablets whereby the human gastro-intestinal tract has an opportunity to acclimate itself to the introduction of the salt.
Accordingly, I have discovered that the impregnation of a salt tablet with refinededible, normally solid waxy material for example, paraffin, beeswax, stearic acid and the like greatly increases the dissolution time thereof to the end that the expected ill effects of the salt, when introduced to the human gastro-intestinal tract are largely avoided.
It is the main objectof my invention to disclose a treatment for retarding the dissolution time and thus the rate of absorption of salt tablets introduced to the human gastro-intestinal tract thereby preventing nausea and irritation of the stomach and related parts of the digestive system.
It is another object of my invention to demonstrate a new and improved sodium chloride tablet, impregnated with parafiin or a like edible waxy material, that is adapted for human consumption for the purpose of avoiding the ill effects of heat exhaustion or the like.
The above objects and further desirablefeatures of my tablet will be recognized by one skilled in the art from'the following detailed description and specifications.
In order to accomplish the desired features set forth above, I prefer to form dense non-friable sodium chloride or salt tablets by a known punching method in a suitable tableting machine under formation pressures ranging from v 5 tons per square inchto tons per square inch. The
Reissued Ne s, 1955 Scum Stu I In carrying out my invention I further prefer the tablets I made from the above grade of salt and punched out under the above formation pressures in a conventional tabletive machine, to' beof a size commercially used in present dispensing machines (i. e. diameter inch,'thickness 0.20 inch, weight l0.t0.5 grains). I introduce tablets of character to a dipping bath of molten, edible, normally solid waxy material, such as refined parafiin, beeswax, stearic acid or other materials of a like nature. Byway of illustration, I shall hereinafter describe a preferred. 7 manner of forming my tablet, which is completelysatisfactory and wherein the dipping bath to which the tablets are introduced consists of refined, molten p'arafin of food grade purity having smelting point ranging from 122' to 124 F., although other paraffins having different melting ranges are available which are equally satisfactory for this purpose. The dipping time in this bath may vary'from 10 to 60 seconds with an average time of'20 seconds being preferred; an increase in dipping time over 2 seconds ap .pearing to have little effect on the parafiin' penetration and dissolution time of my tablet. The eflects of the parafiin penetration are variable according to whether the tablet is punched hard or soft. Formation pressures in the-neighborhood of 5 tons/sq. in. produce a sof tablet while pressures of 10 tons/sq. in. produce a hard tablet. In general thenharder the tablet the less parafiu impregnates the tablet and the less paralfin'impregnation the shorter the disintegration time. Additional variation of the paraflin pentration and impregnation may be obtained by varying the heat of the tablet at the time of dipresults, the following comparative table of parafin skelesalt may vary in its refined quality, but I have found a salt ton weights maybe taken as typical of the relative effects of hardness and dipping temperatures on the impregnation with parafiin a 10 grain tablet of herein. In this table "hot" refers to tablet dipping temperatures of approximately 100' F. while cold refers to normal room temperature. Dipping time is the same for all tablets listed. v
according to conventional practice.
The treatment of the salt tablet in this manner has a I marked effect on its dissolution or disintegration time in water, tending to lengthen this test time over that of an untreated salt tablet. This effect is largely due to a skeletonal impregnating penetration of the tablet by the molten ,parafin whereby an internal honeycomb structure is formed; the separated cells of which encase small individual pockets of salt. [In the presence oLstbmach liquids or other digestive juices of the'human digestive system it appears that the paraflin coated or cellularly separated pockets of salt slowly take on liquid and dissolve within their individual cells; the salt liquid thus gained then osmotically leaks out of these cells into the digestive and gastro-intestinal system in liquid form at a much the rate of dissolution of the sodium chloride tablet obtainable with the present invention is substantially less than that obtainable with a dialyzing film of cellulose acetate or cellulose nitrate. After dissolution of the sodium chloride, the residual internal structure passes harmlessly out of the body by the normal elimination processes.
, In determining the total disintegration time of the tablet I have adapted the standard specified by our Federal Government wherein a salt tablet is suspended in a 10 mesh screen at the 80 milliliter mark of a IOOmilliliter graduate cylinder in l00-milliliters of distilled water at 70' F. The time is then noted until the supporting skeletonal structure rises to the surface. This time represents the total disintegration time of the tablet. By this'test, a plain unimpregnatcd salt tablet will disintegrate in approximately nine minutes. Tablets punched "hard and dipped in molten paraflin for 20 seconds under my above described treatment have an average total distintegrating time of approximately 13 minutes while similar "soft" punched tablets dipped for 20 seconds have an average total disintegration time of approximately 73 minutes. In the above disintegration test figures both the "hard" and soft tablet temperature, upon introduction to the paraflin dip, was that of the surrounding room.
Thus it is observed that my impregnated salt tablet is far superior in disintegration characteristics to that of a plain untreated salt tablet and that by my invention a new and improved medicinal salt tablet is provided, completely satisfactory to the user for dispelling the ill elfects of heat exhaustion or the like without causing undue nausea or of the human digestive equivalent ingredients may be made therein without departing from the spirit and scope of my invention. TI'NIOr,
fore, I do not wish to be limited to the specific illustrations and embodiments herein described other than may appear in the following appended [claim] claims.
Iclaim:
I. As a new article of manufacture, a non-friable, internally reinforced tablet comprising substantially 10 grains of refined granular sodium chloride tableted'under formation pressures of from 5-10 tons per square inch, and an internally disposed cellular structure comprising substantially 8-28 milligrams of refined parafli'n, impregnated between and around the grains of the tableted sodium chloride while in a molten state [said internal cellular structure permitting the osmotic dissolution of said sodium chloride therethrough in the presence of human gastrointestinal juices at a rate substantially less than the normal 'rate of dissolution of sodium chloride in such juices], said internal cellular paraflin structure permitting the disillusnoted between and around the grains of the sodium chloride tablet while in a molten state and subsequently solidi- 5 fled, the formation pressure and amount of way subv stance for the tablet being related substantially as for'rnation pressures of from 5-10 tons per square inch and substantially=8-28 milligrams of waxy substance are related for a tablet comprising substantially 10 grains of sodium chloride.
3. As a new article of manufacture, a non-friable, internally reinforced tablet comprising grains of refined granue. larsodium chloride tableted under formation pressure into squa're'irich and substantially 8-28 milligrams of waxy 0 substance are related for a tablet comprising substantially 10 grains of sodium chloride, said intern'al cellular paraffin structure permitting dissolution of said sodium chloride in the stomach at a rate substantially less than the normal rate ofdissolution of sodium chloride in the stomach.
: References Cited in the file' of this patent or the original patent UNITED STATES PATENTS 60 1,498,666 Mason, June 24, 1924 2,011,587 Miller Aug. 20, 1935 2,373,763 Kuever Apr. l7, 1945 2,478,182 Consolan'o Aug. 9, 1949 2,540,979 Clymer Feb. 6,1951
omen REFERENCES Jour. Amer. Pharm. Assn.-, Pharm. Abs., April 1944, a page 105.
sion of said sodium chloride therethrough in the presence
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USRE24090E true USRE24090E (en) | 1955-11-15 |
Family
ID=2091926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US24090D Expired USRE24090E (en) | Impregnated salt tablet |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | USRE24090E (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2887438A (en) * | 1956-03-27 | 1959-05-19 | Ciba Pharm Prod Inc | Prolonged action tablets |
| US2918411A (en) * | 1957-11-01 | 1959-12-22 | Olin Mathieson | Pharmaceutical preparations |
| US3082154A (en) * | 1960-04-19 | 1963-03-19 | Ici Ltd | Improved free-flowing coated antimalarial salts in particulate form |
| US3087860A (en) * | 1958-12-19 | 1963-04-30 | Abbott Lab | Method of prolonging release of drug from a precompressed solid carrier |
| US3132067A (en) * | 1960-03-31 | 1964-05-05 | Rauscher Herbert | Metal phosphide compositions and a process for their production |
| US3317394A (en) * | 1955-12-22 | 1967-05-02 | Haessle Ab | Medicinal tablet and a method for its preparation |
| US3402240A (en) * | 1957-06-25 | 1968-09-17 | Pfizer & Co C | Medicinal tablet and process of making same |
| US4726952A (en) | 1983-08-11 | 1988-02-23 | Mission Pharmacal | Slow-release sodium fluoride tablet, method of making, and method of treatment of osteoporosis |
-
0
- US US24090D patent/USRE24090E/en not_active Expired
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3317394A (en) * | 1955-12-22 | 1967-05-02 | Haessle Ab | Medicinal tablet and a method for its preparation |
| US2887438A (en) * | 1956-03-27 | 1959-05-19 | Ciba Pharm Prod Inc | Prolonged action tablets |
| US3402240A (en) * | 1957-06-25 | 1968-09-17 | Pfizer & Co C | Medicinal tablet and process of making same |
| US2918411A (en) * | 1957-11-01 | 1959-12-22 | Olin Mathieson | Pharmaceutical preparations |
| US3087860A (en) * | 1958-12-19 | 1963-04-30 | Abbott Lab | Method of prolonging release of drug from a precompressed solid carrier |
| US3132067A (en) * | 1960-03-31 | 1964-05-05 | Rauscher Herbert | Metal phosphide compositions and a process for their production |
| US3082154A (en) * | 1960-04-19 | 1963-03-19 | Ici Ltd | Improved free-flowing coated antimalarial salts in particulate form |
| US4726952A (en) | 1983-08-11 | 1988-02-23 | Mission Pharmacal | Slow-release sodium fluoride tablet, method of making, and method of treatment of osteoporosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USRE24090E (en) | Impregnated salt tablet | |
| JP3125847B2 (en) | Method for easily disintegrating gel layer of gel-coated seed | |
| US4975295A (en) | Instant coffee tablets | |
| US4645664A (en) | Microporous powder form polylactides | |
| DE2821703B2 (en) | Salt mixes for making cold mixes | |
| FI64563C (en) | PROCEDURE FOR STABILIZATION OF ENVIRONMENTAL PRODUCTS | |
| US2054624A (en) | Curing salt mass | |
| US2665236A (en) | Impregnated salt tablet | |
| US2390088A (en) | Enteric gelatin capsule shell or envelope | |
| JPH11222796A (en) | Antibacterial paper and packaging materials | |
| US4987031A (en) | Capsule | |
| JPH05132570A (en) | Moisture-resistant polysaccharide film | |
| JP4113310B2 (en) | Tablet-shaped liquid food element | |
| CN100377746C (en) | Method of stabilizing preparation | |
| JPS6110508A (en) | Capsule and its production | |
| US2245576A (en) | Method of protecting and preserving food products | |
| US1498666A (en) | Tablet | |
| JP2004175746A (en) | Soft capsule and method for producing the same | |
| JPS6012946A (en) | Raw noodles to be boiled rapidly and its preparation | |
| US2196283A (en) | Capsule | |
| US5910281A (en) | Method for restoring dried aqueous organic gel capsules | |
| JPH05148388A (en) | Polysaccharide film | |
| JPS57140710A (en) | Capsule agent for rectal administration | |
| JPH04372627A (en) | polysaccharide film | |
| US3095281A (en) | Process for the preparation of common salt by the evaporation of solutions |